Genomic Mutations of Primary and Metastatic Lung Adenocarcinoma in Chinese Patients

Figure 4

Actionability of genomic mutations in primary tumors and metastases. (a) The actionability is divided into five levels. (b) The distribution of genomic mutations at different levels is compared between primary tumors and metastases. (c) The actionable levels of genomic mutations in primary tumors are sorted by frequency. (d) The actionable levels of genomic mutations in metastases are sorted by frequency.

(a)

(b)

(c)

(d)